Wen-Hsuan Tsai, Fung-Chang Sung, Fung-Chang Sung, Fung-Chang Sung, Lu-Ting Chiu, Ying-Hsiu Shih, . . . Shu-I Wu. (2022). Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study. Frontiers Media S.A..
Chicago Style (17th ed.) CitationWen-Hsuan Tsai, Fung-Chang Sung, Fung-Chang Sung, Fung-Chang Sung, Lu-Ting Chiu, Ying-Hsiu Shih, Ming-Chieh Tsai, Shu-I Wu, and Shu-I Wu. Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationWen-Hsuan Tsai, et al. Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study. Frontiers Media S.A., 2022.